Lipocine Inc.
Lipocine Inc.（LPCN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
lpcn · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$15.00
Consensus
$10.50
+414.7% upside
Low
$6.00
Median: $10.5 · Last Close: $2.04
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$10.50
414.7% upside
High Target
$15
635.3%
Low Target
$6
194.1%
Current Price
$2.04
as of today
Based on analyst price targets, the LPCN stock price prediction for the next 12 months ranges from $6 to $15. The consensus LPCN price forecast of $10.50 implies 414.7% upside from the current price of $2.04.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.00 | ↓ 2.20% |
1-day model range: $1.98–$2.01. Peak: $2.01 (-2.20%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · LPCN · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-06 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-07-27 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2021-08-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-06-24 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2021-05-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Lipocine Inc. (LPCN) stock. Of the recent 20 rating actions, 2 were upgrades and 2 were downgrades. 9 analysts currently cover LPCN.
分析师推荐趋势
LPCN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 51.0% YoY
Revenue Next Year
$1M
↑ 85.4% YoY
EPS This Year
$-1.91
EPS Next Year
$-1.65
↓ 13.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast LPCN EPS of $-1.91 for the current fiscal year, based on estimates from 1 analysts. The LPCN revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
LPCN 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LPCN 的共识目标价为 $10.50（+414.7% 上行空间），分析师共识为 Buy。
LPCN 的短期预测（明日）为 $2.00（-2.20%）。
Lipocine Inc. 在 NASDAQ 上市，代码 LPCN。LPCN 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
LPCN 预测 · 8 个问题根据 9 位华尔街分析师，LPCN 的 12 个月平均目标价为 $10.50，最高 $15.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $2.04，隐含约 +414.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.